
Opinion|Videos|July 12, 2024
Factors Influencing Choice of Second-Generation BTKi Monotherapy
Specialists discuss factors influencing the choices of second-generation BTK monotherapy.
Advertisement
Episodes in this series

Video content above is prompted by the following question(s):
- When considering monotherapy with second-generation BTKi, what factors do you consider when choosing between available agents?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Mirvetuximab Soravtansine Demonstrates Promising Efficacy, Safety in Platinum-Resistant Recurrent Ovarian Cancer
2
How Artificial Intelligence Is Transforming Leukemia Detection and Diagnosis
3
Zanubrutinib Shows Similar Efficacy but Better Safety Than VEN–I in Frontline CLL
4
FDA Approves Sibeprenlimab for Immunoglobulin A Nephropathy
5













































